⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
INBX News
Inhibrx Biosciences, Inc. Common Stock
Form 8-K
sec.gov
INBX
Inhibrx Reports Fourth Quarter and Fiscal Year 2025 Financial Results
prnewswire.com
INBX
SNY
Inhibrx Announces Participation in Upcoming Scientific Conference
prnewswire.com
INBX
Form 8-K
sec.gov
INBX
InboxAlly Wins the Winter 2026 Top Performer Award for Email Deliverability Software from SourceForge
globenewswire.com
INBX
Inhibrx Biosciences Provides Progress Updates on the INBRX-106 Program and the Expansion Cohorts of the ozekibart (INBRX-109) Program
prnewswire.com
INBX
Inhibrx Reports Third Quarter 2025 Financial Results
prnewswire.com
INBX
Inhibrx Announces Participation in Upcoming Scientific Conferences
prnewswire.com
INBX
Inhibrx Biosciences Reports Positive Topline Results from its Registrational Trial of Ozekibart (INBRX-109) in Chondrosarcoma and Provides Updates on Colorectal Cancer and Ewing Sarcoma Expansion Cohorts
prnewswire.com
INBX